| Student | Research Project | Based at: |
| 2017-2020 Georgia Stavrou | Validation and use of Human intestinal epithelial organoids as models to study paediatric IBD pathogenesis | Addenbrookes Hospital, Cambridge |
| 2016-2019 Rai Shashank | Can inhibition of caspase-3 offset genetic predisposition to Crohn’s Disease? | University of East Anglia |
| 2016-2019 Daniel Brice | Interleukin-27 responses in inflammatory bowel disease – a potential new therapeutic? | Aberdeen University |
| 2014-2016 Kirsty Hooper | An investigation of commonly used IBD drugs on autophagy pathway activity and potential therapeutic benefit for treatment of paediatric IBD | Edinburgh Napier |
| 2013-2016 Judith Kraiczy | Epigenetics in Paediatric IBD | Cambridge University |
| 2012-2015 Lucas Neiddereider | The study of gene defect (XBP1) | Cambridge University |
| 2012-2015 Gala Andreoletti | Genomic informatics focussed on Paediatric IBD | Southampton University |
| 2010-2013 Jessica Thomas | Studying the cells in the intestine that make antibodies, and cells that regulate them | Kings College London |
| 2011–2014 Alex Adams | Characterisation of genome-wide Epigenetic alterations in childhood onset Crohn’s disease | Edinburgh University |
| 2007-2010 Peter Morrison | L-23 and Th17 cells in Helicobacter induced intestinal Inflammation | York University |
| 2006-2009 Nichola Gellately | Mucosal dentritic cell function | St. Bartholomew’s & The Royal London |
| 2003-2006 Ida Riciardelli | Exploration of how current therapeutic strategies can influence the destiny and function of regulatory lymphocytes | Institute of Child Health, London |
| 2000-2003 Marcus Bachler | The possible role of the OX40 as a new treatment for Crohn’s disease | Southampton Hospital |
| 2000-2003 Cassie Davies | Quality of Life study | Booth Hall Children’s Hospital, Manchester |
| 1999-2003 Lindsey Edwards | Intestinal responses to bacterial components as risk factors for IBD | Royal Free Hospital, London |
| 1995-1997 Natalie Goncalves | Development, mechanisms and therapies of the immune gut injury in the IL-2 KO model | Paediatric Gastroenterology Laboratory, St. Bartholomew’s Hospital, London |
| 1994-1996 Lisa Higgins | Co-stimulatory molecules involved in the pathogenesis of inflammatory bowel disease | St. Bartholomew’s Research Centre, London |
| 1992-1994 Stuart MacDonald | Investigating the mechanisms of intestinal injury in genetically – modified mice lacking the Interleukin-2 | St. Bartholomew’s Research Centre, London |
| 1992-1995 Sylvia Pender (nee Cheng) | Extra cellular matrix protein degradation during intestinal damage | St. Bartholomew’s Research Centre, London |
| 1989-1991 Anna Bellhouse | A Study on Gamma-delta T cells | St. Bartholomew’s Research Centre, London |
| 1989-1991 Jacqueline Taylor | Activated T-cells and their effect on gut inflammation | St. Bartholomew’s Research Centre, London |
| 1986-1988 Louise Forsyth | Mechanisms of T-cell mediated damage in human small intestinee | St. Bartholomew’s Research Centre, London |
| 1986-1989 Teresa Monk | Mechanisms of T-cell mediated damage in human small intestine | St. Bartholomew’s Research Centre, London |
| 1985-1988 Jo Viney | The phenotype and function of intraepithelial lymphocytes | St. Bartholomew’s Research Centre, London |
